Global Cardiac Resynchronization Therapy Market Size & Outlook

The global cardiac resynchronization therapy market size was estimated at USD 5,048.8 million in 2025 and is projected to reach USD 8,213.1 million by 2033, growing at a CAGR of 6.3% from 2026 to 2033.
Revenue, 2025 (US$M)
$5,048.8
Forecast, 2033 (US$M)
$8,213.1
CAGR, 2026 - 2033
6.3%
Report Coverage
Worldwide

Global cardiac resynchronization therapy market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global cardiac resynchronization therapy market highlights

  • The global cardiac resynchronization therapy market generated a revenue of USD 5,048.8 million in 2025 and is expected to reach USD 8,213.1 million by 2033.
  • The market is expected to grow at a CAGR (2026 - 2033) of 6.3% by 2033.
  • In terms of segment, crt-defibrillator accounted for a revenue of USD 2,891.6 million in 2025.
  • CRT-Pacemaker is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2025.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.

Global data book summary

Market revenue in 2025USD 5,048.8 million
Market revenue in 2033USD 8,213.1 million
Growth rate6.3% (CAGR from 2026 to 2033)
Largest segmentCrt-defibrillator
Fastest growing segmentCRT-Pacemaker
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCRT-Defibrillator, CRT-Pacemaker

Other key industry trends

  • In terms of revenue, the North America accounted for 52.7% of the global cardiac resynchronization therapy market in 2025.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, UK is the fastest growing regional market and is projected to reach USD 344.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cardiac Resynchronization Therapy Market Companies

Name Profile # Employees HQ Website
MicroPort Scientific Corp View profile 8230 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 https://www.microport.com
BIOTRONIK View profile 5001-10000 Berlin, Berlin, Germany, Europe https://www.biotronik.com/de-de
LivaNova PLC View profile 2900 20 Eastbourne Terrace, London, United Kingdom, W2 6LG https://www.livanova.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Global cardiac resynchronization therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac resynchronization therapy market will help companies and investors design strategic landscapes.


Crt-defibrillator was the largest segment with a revenue share of 57.27% in 2025. Horizon Databook has segmented the Global cardiac resynchronization therapy market based on crt-defibrillator, crt-pacemaker covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Cardiac Resynchronization Therapy Product Outlook (Revenue, USD Million, 2021-2033)
    • CRT-Defibrillator
    • CRT-Pacemaker
  • Global Cardiac Resynchronization Therapy End Use Outlook (Revenue, USD Million, 2021-2033)
    • Cardiac Centers
    • Hospitals
    • Others End Use

Reasons to subscribe to Global cardiac resynchronization therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global cardiac resynchronization therapy market databook

  • Our clientele includes a mix of cardiac resynchronization therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global cardiac resynchronization therapy market , including forecasts for subscribers. This global databook contains high-level insights into Global cardiac resynchronization therapy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global cardiac resynchronization therapy market size, by regions, 2021-2033 (US$M)

Top 10 countries: Cardiac resynchronization therapy market size, 2025 (US$M)

Global cardiac resynchronization therapy market share, by end use, 2025 & 2033 (%, US$M)

Cardiac resynchronization therapy market: Opportunity assessment by country

Global cardiac resynchronization therapy market, by region, 2025 (US$M)

Global cardiac resynchronization therapy market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online